Emergent BioSolutions Inc. - COMMON STOCK (EBS)

CUSIP: 29089Q105

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / COMMON STOCK
Shares outstanding
52,870,098
Total 13F shares
43,408,353
Share change
+1,664,144
Total reported value
$536,508,668
Put/Call ratio
37%
Price per share
$12.36
Number of holders
181
Value change
+$24,746,407
Number of buys
95
Number of sells
77

Quarterly Holders Quick Answers

What is CUSIP 29089Q105?
CUSIP 29089Q105 identifies EBS - Emergent BioSolutions Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Emergent BioSolutions Inc. - COMMON STOCK (EBS) as of Q4 2025

As of 31 Dec 2025, Emergent BioSolutions Inc. - COMMON STOCK (EBS) was held by 181 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 43,408,353 shares. The largest 10 holders included BlackRock, Inc., OAK HILL ADVISORS LP, VANGUARD GROUP INC, STATE STREET CORP, AMERICAN CENTURY COMPANIES INC, DIMENSIONAL FUND ADVISORS LP, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, PALISADE CAPITAL MANAGEMENT, LP, GEODE CAPITAL MANAGEMENT, LLC, and MORGAN STANLEY. This page lists 181 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.